So what medium to large Pharma is going to put up the first 10 to 20 million (peanuts to most of them) to get a potential piece of 600000 to 1.2 billion revenue...
I believe SOMEBODY blinked.. and we get the good news soon
Now that our share price is showing some life.. I agree it opens up other options as well..
This is the reality and the potential investors are buying into..
If a deal is struck (partnership).. then imo sky is the limit..
If a P3 trial with 100 patients was part of the "acceptable Brilacidin Phase 3 development pathway" don't you think that this Company would have put a big sign in the window in Beverly that said that? I would have expected news like that to have appeared prominently in the "Innovation Pharmaceuticals Receives FDA End-of-Phase 2 Meeting Minutes" press release...the one that didn't include any "more details regarding planned Phase 3 trials of Brilacidin" than those that appeared in the release in which that expectation was offered up. It would easily qualify as a good news "more detail".
Could be months if it CAN be proven effective. Keep in mind Galera Therapeutics, who started a phase 3 in S-OM in October, 2018, lists their primary completion date as October 2020 and study completion date as October 2024(they also raised 150M last September).